Cargando…
Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region
Introduction: SARS-CoV-2 antigen tests can complement and substitute for RT-PCR tests. Centralized laboratory automated SARS-CoV-2 antigen tests that can be scaled to process a large number COVID-19 cases simultaneously are now available. We have evaluated the new Roche Elecsys SARS-CoV-2 antigen el...
Autores principales: | Lau, Chin Shern, Phua, Soon Kieng, Hoo, See Ping, Jiang, Boran, Aw, Tar-Choon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875833/ https://www.ncbi.nlm.nih.gov/pubmed/35214657 http://dx.doi.org/10.3390/vaccines10020198 |
Ejemplares similares
-
Multicentre evaluation of the Roche Elecsys® Active B(12) (holotranscobalamin) electro-chemiluminescence immunoassay
por: Heil, Sandra G, et al.
Publicado: (2019) -
Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms
por: Lau, C.S., et al.
Publicado: (2021) -
Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA)
por: Lee, Deborah J. W., et al.
Publicado: (2023) -
Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
por: CS, Lau, et al.
Publicado: (2021) -
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Lau, Chin-Shern, et al.
Publicado: (2021)